Onkos Surgical announced today that the FDA has cleared its My3D personalized pelvic reconstruction system.
My3D expands Onkos Surgical’s portfolio to include systems to treat pelvic conditions.
The Parsippany, New Jeresey–based company said My3D includes 3D-printed implants, instruments and models. There is also an advanced planning service to treat deformity, trauma, disease and revisions. There are patient-specific implants for both acetabular reconstruction and advanced reconstruction that span multiple regions of the pelvis.
“Patients with these conditions of the pelvis have many clinical challenges. Historically, our implant options are mass-produced and may not be best suited for the individuality that each patient requires. With this platform, Onkos has developed a process that allows me to virtually plan the surgery in advance and delivers a patient-specific implant and instruments in a matter of weeks. It changes the way I can treat…